Aktiia
Private Company
Total funding raised: $47.5M
Overview
Aktiia is a pioneering medical device company that has developed the first CE-marked, cuffless blood pressure monitor for 24/7 automated measurement. Its core technology, based on optical sensors and proprietary algorithms, has been validated in multiple clinical trials published in peer-reviewed journals like Nature. The company is commercializing its Class IIa medical device across Europe, targeting both consumer health and clinical research markets with a data-driven approach to hypertension management.
Technology Platform
Optical Blood Pressure Monitoring (OBPM™) platform using a wearable device with photoplethysmography (PPG) sensors and proprietary algorithms to enable cuffless, automated, 24/7 blood pressure measurement.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Aktiia competes with traditional home BP monitor companies (Omron, Withings), ambulatory BP monitor providers, and a growing field of tech companies developing cuffless optical sensing (e.g., Apple, Samsung). Its primary competitive advantage is its early CE Mark as a Class IIa device and strong publication record in peer-reviewed journals validating clinical accuracy.